KRAS and non-small cell lung carcinoma: Since compound 0375-0604 bound to KRAS in vitro, we further determined its cytotoxicity in NSCLC cell lines harboring mutant KRAS by using MTT assay, including H2122 (KRASG12C), H358 (KRASG12C) and H460 (KRASQ61H) cell lines.